Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, CB2 1GA, Cambridge, UK.
Gene Editing Discovery and Engineering, Genomic Medicine, Bayer AG, Nattermannallee 1, Cologne, 50829, Germany.
Nat Commun. 2023 Feb 11;14(1):768. doi: 10.1038/s41467-023-36099-7.
Tailoring of the activity and specificity of proteases is critical for their utility across industrial, medical and research purposes. However, engineering or evolving protease catalysts is challenging and often labour intensive. Here, we describe a generic method to accelerate this process based on yeast display. We introduce the protease selection system A2M that covalently captures protease catalysts by repurposed alpha-2-macroglobulin (A2Ms). To demonstrate the utility of A2M for protease engineering we exemplify the directed activity and specificity evolution of six serine proteases. This resulted in a variant of Staphylococcus aureus serin-protease-like (Spl) protease SplB, an enzyme used for recombinant protein processing, that no longer requires activation by N-terminal signal peptide removal. SCHEMA-based domain shuffling was used to map the specificity determining regions of Spl proteases, leading to a chimeric scaffold that supports specificity switching via subdomain exchange. The ability of A2M to overcome key challenges en route to tailor-made proteases suggests easier access to such reagents in the future.
针对不同的工业、医疗和研究用途,对蛋白酶的活性和特异性进行调整是至关重要的。然而,对蛋白酶催化剂进行工程改造或进化是具有挑战性的,而且通常需要大量的人力。在这里,我们描述了一种基于酵母展示的通用方法来加速这一过程。我们引入了蛋白酶选择系统 A2M,该系统通过重新利用的α-2-巨球蛋白(A2M)共价捕获蛋白酶催化剂。为了证明 A2M 在蛋白酶工程中的实用性,我们举例说明了六种丝氨酸蛋白酶的定向活性和特异性进化。这导致了金黄色葡萄球菌丝氨酸蛋白酶样(Spl)蛋白酶 SplB 的变体的产生,这种酶用于重组蛋白加工,不再需要通过 N 端信号肽去除来激活。基于 SCHEMA 的结构域改组用于映射 Spl 蛋白酶的特异性决定区域,导致支持通过亚结构域交换进行特异性切换的嵌合支架。A2M 克服了定制蛋白酶过程中的关键挑战的能力表明,未来更容易获得此类试剂。